The article presents two cases of hepatitis-associated aplastic anemia in the last year. The literature data on the new nosology are presented. The clinical picture, diagnosis and treatment are discussed. The questions of diagnosis and treatment that affect the prognosis are raised. Treatment preference should be given to allogeneic bone marrow transplantation, as it has better results than aggressive immunosuppressive therapy that is difficult for patients to tolerate.
Kosterina A.V., Nazipova Z.M., Marapov D.I. The effectiveness of the use of immunosuppressive therapy and splenectomy in the treatment of patients with aplastic anemia on the example of the experience of the Department of Hematology of the RCH // Practical Medicine. - 2016. - No. 4 (96). - S. 68-72. [in russian]
Brown K.E., Tisdale J., Barrett A.J., et al. Hepatitis-associated aplastic anemia // N. Engl. J. Med. ― 1997. ― 336. ― P. 1059.
Osugi Y., Yagasaki H., Sako M., et al. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia // Haematologica. ― 2007. ― 92. ― P. 1687.
Ohara A., Kojima S., Okamura J., et al. Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-associated aplastic anaemia // Br. J. Haematol. ― 2002. ― 116. ― P. 151.
Савченко В.Г. Клинические рекомендации по лечению апластической анемии // Национальное гематологическое общество. ― 2014. ― С. 8-22.